Washington, DC 20006-5349
HELPLINE
Charity Navigator has awarded the Meso Foundation its highest rating, reserved for organizations that exceed industry standards and outperform most charities in their cause. Charity…
As of June 1, Dr. Kiran Turaga, a surgeon from the Medical College of Wisconsin, will be joining Dr. Hedy Kindler and the University of…
On April 26, we had the opportunity to attend Bloomberg Government’s conference on Building the Big Data Economy: Personalized care and cancer treatment in the…
For cancer patients, a diagnosis is generally followed by staging. Among other things, the stage of a cancer tells the patient and physician if the…
Just today, we learned that Verastem, a biotech company that has previously done research in mesothelioma, has now embarked on several new projects. In the…
In the latest iteration of its budget bill, Congress included $50 million for the Department of Defense’s (DoD) Peer Reviewed Cancer Research Program (PRCRP). The…
Today, Congress voted and passed its budget bill, which included a nearly indefinite renewal of the Zadroga Act, which provides heathcare for first responders and…
This week, we announced the release of a search tool which will enable users on the Meso Foundation’s website to easily search through nearly 100…
The Meso Foundation is pleased to announce that Tobias Peikert, MD, of Mayo Clinic, has taken on the role of its Science Advisory Board’s chair. The…
On October 14, the SELLAS Life Sciences Group, a biotech company leading a Phase 2 study of the WT1 vaccine, released the study’s promising data. The…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
